Also categorized in BoardNews:
Why Should We Care About Corporate Interlocks?
x hide permanently

Investors are Angry with Botox-Maker Allergan — and They're Trying to Get an Activist Involved to Shake It Up

Business Insider
  • Some of Allergan's top shareholders have approached potential activist investors to gauge their interest in pushing for change at the Botox-maker, according to people familiar with the matter.
  • Allergan's shares are down 33% in the last year, compared to a 7% rise for the Nasdaq Biotech Index.
  • Allergan is set to report earnings on April 30...
Mentions: Activist Investors Investors Credit Suisse